ArticleOxford medical case reports2025
Squamous cell carcinoma in an umbilical cyst: a clinical image.
Article in Oxford medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 49-year-old woman presented with a chronic, painful umbilical mass refractory to antibiotics and incision and drainage, ultimately diagnosed as well-differentiated squamous cell carcinoma (SCC) with positive margins. Imaging revealed an abnormal left inguinal lymph node, and biopsy confirmed metastatic disease. She underwent wide local excision with abdominal wall reconstruction and completion inguinal lymphadenectomy, which demonstrated extranodal extension in 2 of 10 nodes. Adjuvant radiotherapy was administered to the left groin, but surveillance imaging five months later showed progression to retroperitoneal and periaortic lymphadenopathy. She is currently receiving cemiplimab immunotherapy, highlighting the importance of multimodal management in treating rare primary abdominal wall SCC. As much of the literature and prior reports focus on cutaneous SCC, this case provides a unique insight into the diagnosis, treatment, and future of care in aggressive metastatic non-cutaneous primary SCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.